Ivan Astralaga
Corporate Officer/Principal bei C-RAD AB
Vermögen: 72 618 $ am 30.04.2024
Aktive Positionen von Ivan Astralaga
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
C-RAD AB | Corporate Officer/Principal | 21.05.2021 | - |
Karriereverlauf von Ivan Astralaga
Ehemalige bekannte Positionen von Ivan Astralaga
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Vertrieb & Marketing | 01.08.2019 | 01.04.2021 |
Statistik
International
Schweden | 2 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 1 |
Sales & Marketing | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
C-RAD AB | Health Technology |
Private Unternehmen | 1 |
---|---|
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Health Technology |
- Börse
- Insiders
- Ivan Astralaga
- Erfahrung